Real-world effectiveness of pembrolizumab in previously treated non-small cell lung cancer: A population-based cohort study.

Rodrigo MurteiraFábio Cardoso BorgesGonçalo Pinto MendesCatarina RamosAdriana RamosPatrícia SoaresCláudia FurtadoAna MirandaFilipa Alves da Costanull null

Published in: Pharmacoepidemiology and drug safety (2020)

Real-world data suggest the performance of pembrolizumab to reflect the clinical trial outcomes in previously treated NSCLC.

Keyphrases